600713 Stock Overview
Engages in the pharmaceutical wholesale and retail businesses in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
NanJing Pharmaceutical Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.50 |
| 52 Week High | CN¥5.63 |
| 52 Week Low | CN¥3.85 |
| Beta | 0.42 |
| 11 Month Change | 15.79% |
| 3 Month Change | 29.41% |
| 1 Year Change | 6.80% |
| 33 Year Change | 22.22% |
| 5 Year Change | 26.73% |
| Change since IPO | 170.62% |
Recent News & Updates
NanJing Pharmaceutical's (SHSE:600713) Earnings Seem To Be Promising
Nov 06
Is NanJing Pharmaceutical (SHSE:600713) Using Too Much Debt?
Oct 28Shareholder Returns
| 600713 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 7.8% | -2.9% | -3.4% |
| 1Y | 6.8% | -12.7% | 6.1% |
Return vs Industry: 600713 exceeded the CN Healthcare industry which returned -12.7% over the past year.
Return vs Market: 600713 matched the CN Market which returned 6.1% over the past year.
Price Volatility
| 600713 volatility | |
|---|---|
| 600713 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 600713 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600713's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 4,903 | Liang Zhang | www.njyy.com |
NanJing Pharmaceutical Company Limited engages in the pharmaceutical wholesale and retail businesses in China. It also operates various pharmacies and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.
NanJing Pharmaceutical Company Limited Fundamentals Summary
| 600713 fundamental statistics | |
|---|---|
| Market cap | CN¥7.02b |
| Earnings (TTM) | CN¥579.41m |
| Revenue (TTM) | CN¥53.98b |
12.4x
P/E Ratio0.1x
P/S RatioIs 600713 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600713 income statement (TTM) | |
|---|---|
| Revenue | CN¥53.98b |
| Cost of Revenue | CN¥50.61b |
| Gross Profit | CN¥3.37b |
| Other Expenses | CN¥2.79b |
| Earnings | CN¥579.41m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 6.24% |
| Net Profit Margin | 1.07% |
| Debt/Equity Ratio | 147.4% |
How did 600713 perform over the long term?
See historical performance and comparison